Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : LIPO-Liposome -- Ignore unavailable to you. Want to Upgrade?

To: Brian Malloy who wrote (832)	9/16/1999 9:41:00 PM
From: get shorty	Respond to of 900

Well played Brian and you will be rewarded! shorty

To: Brian Malloy who wrote (832)	9/16/1999 11:21:00 PM
From: KM	Read Replies (1) \| Respond to of 900

Oh well. My position was very small, a pure gamble, bought with profits from another trade. This ought to be a helluva daytrader tomorrow so I ought to be able to get most, if not all back by scalping. Que sera. I do feel sympathy for the investors on this board, though. We'll have to follow along with Avalon in the future, it seems. I thought the point that the FDA panel used as a rejection was interesting. If any of the docs on the board wanted to comment, I'd like to read it. Is it your opinion that the efficacy of this drug is not equal to plain doxorubicin? Did the company not submit studies to address this issue? Is there an appeaal process?